Skip to main content Accessibility help
×
Home
Hostname: page-component-56f9d74cfd-h5t46 Total loading time: 1.462 Render date: 2022-06-26T21:27:00.732Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "useNewApi": true }

Section VI - Cancer Screening and Prevention

Published online by Cambridge University Press:  20 February 2019

David Chelmow
Affiliation:
Virginia Commonwealth University
Nicole W. Karjane
Affiliation:
Virginia Commonwealth University
Hope A. Ricciotti
Affiliation:
Harvard Medical School
Amy E. Young
Affiliation:
University of Texas, Austin
Get access
Type
Chapter
Information
Office Gynecology
A Case-Based Approach
, pp. 114 - 137
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Moscicki, A. HPV infections in adolescents. Disease Markers 2007;23:229234.CrossRefGoogle ScholarPubMed
American College of Obstetricians and Gynecologists. Cervical cancer screening and prevention. Practice bulletin No. 168. Obstet Gynecol 2016;128:111130.CrossRef
American College of Obstetricians and Gynecologists. Management of abnormal cervical cancer screening test results and cervical cancer precursors. Practice Bulletin No. 140. Obstet Gynecol 2013;122:13381367.CrossRef
Katki, HA, Schiffman, M, Castle, PE et al.Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines. J Low Genit Tract Dis 2013;17 (5 Suppl 1):S28.CrossRefGoogle ScholarPubMed
Benard, VB, Watson, M, Castle, PE, Saraiya, M. Cervical carcinoma rates among young females in the United States. Obstet Gynecol 2012;120:11171123.Google ScholarPubMed
Cox, JT, Schiffman, M, Solomon, D. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol 2003;188:14061412.CrossRefGoogle ScholarPubMed
Katki, HA1, Schiffman, M, Castle, PE et al. Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years. J Low Genit Tract Dis 2013;17 (5 Suppl 1): S64S68.CrossRefGoogle ScholarPubMed
Massad, L, Einstein, M, Huh, W et al. 2012 Updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2013;17 (5 Suppl 1): S1S2.CrossRefGoogle Scholar
Arbyn, M, Sasieni, P, Meijer, CJ et al. Chapter 9: Clinical applications of HPV testing : a summary of meta-analyses. Vaccine 2006;24 (suppl 3): S78S89.CrossRefGoogle ScholarPubMed
Waxman, AG, Chelmow, D, Darragh, TM, Lawson, H, Moscicki, AB. Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix. Obstet Gynecol 2012 December;120(6):14651471.CrossRefGoogle ScholarPubMed
Moscicki, A, Ma, Y, Wibbelsman, C et al. Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet Gynecol 2010;116:13731380.CrossRefGoogle ScholarPubMed
American College of Obstetricians and Gynecologists. Lynch syndrome. Practice bulletin No. 147. Obstet Gynecol 2014;124:10421054.CrossRef
Barrow, E, Hill, J, Evans, DG. Cancer risk in Lynch syndrome. Fam Cancer 2013;12(2):229240.CrossRefGoogle ScholarPubMed
Nakamura, K, Banno, K, Yanokura, M et al. Features of ovarian cancer in Lynch syndrome. Mol Clin Oncol. 2014;2(6):909916.CrossRefGoogle ScholarPubMed
Lu, KH, Dinh, M, Kohlmann, W et al. Gynecologic cancer as a “sentinel cancer” for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol 2005;105:569574.CrossRefGoogle ScholarPubMed
Vasen, H, Watson, P, Mecklin, JP, Lynch, H. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999;116(6):14531456.CrossRefGoogle Scholar
Umar, A, Boland, CR, Terdiman, JP et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004;96(4):261268.CrossRefGoogle ScholarPubMed
National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Genetic/Familial High-Risk Assessment: Colorectal. Version 1.2017. Available at NCCN.org.
Lindor, NM, Petersen, GM, Hadley, DW et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006;296:15071517.CrossRefGoogle ScholarPubMed
Burn, J, Gerdes, AM, Macrae, F et al. CAPP2 Investigators: long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 2011;378:20812087.CrossRefGoogle ScholarPubMed
Schmeler, K, Lynch, HT, Chen, L et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch Syndrome. N Engl J Med 2006;354:261269.CrossRefGoogle ScholarPubMed
Hampel, H. Genetic counseling and cascade genetic testing in Lynch syndrome. Fam Cancer 2016;15:423427.CrossRefGoogle ScholarPubMed
Stoffel, EM, Ford, B, Mercado, RC et al. Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin Gastroenterol Hepatol 2008;6(3):333338.CrossRefGoogle ScholarPubMed
American Medical Association, Code of Medical Ethics. Opinion E-2.131: Disclosure of Familial Risk in Genetic Testing. www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-medical-ethics/opinion2131.page. Accessed 11 January 2013.
Duesing, N, Schwarz, J, Choschzick, M et al. Assessment of cervical intraepithelial neoplasia with colposcopic biopsy and efficacy of loop electrosurgical excision procedure. Arch Gynecol Obstet 2012;286:15491554.CrossRefGoogle ScholarPubMed
Ghaem-Maghami, S, Sagi, S, Majeed, G, Soutter, W P. Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis. Lancet Oncology 2007;8(11):985993.CrossRefGoogle ScholarPubMed
Liss, J, Alston, M, Krull, MB, Mazzoni, SE. Predictors of positive margins at time of Loop Electrosurgical Excision Procedure. J Low Genit Tract Dis 2017:21(1):6466.CrossRefGoogle ScholarPubMed
McCredie, MR, Sharples, KJ, Paul, C et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008;9:425434.CrossRefGoogle ScholarPubMed
Felix, JC, Muderspach, LI, Duggan, BD, Roman, LD. The significance of positive margins in loop electrosurgical cone biopsies. Obstet Gynecol 1994;84(6):9961000.Google ScholarPubMed
Temkin, SM, Hellmann, M, Lee, YC, Abulafia, O. Dysplastic endocervical curettings: a predictor of cervical squamous cell carcinoma. Am J Obstet Gynecol 2007 May;196(5):469.e1469.e4CrossRefGoogle ScholarPubMed
Massad, SL, Einstein, MH, Huh, WK et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2013;17: S1S27.CrossRefGoogle ScholarPubMed
Ayhan, A, Boynukalin, FK, Guven, S et al. Repeat LEEP conization in patients with cervical intraepithelial neoplasia grade 3 and positive ectocervical margins. Int J Gynaecol Obstet 2009:105(1):1417.CrossRefGoogle ScholarPubMed
Bansal, N, Wright, JD, Cohen, CJ, Herzog, TJ. Natural history of low grade cervical intraepithelial lesions. Anticancer Res 2008 May–June;28(3B):17631766.Google Scholar
Jin, G, Lanlan, Z, Li, C, Dan, Z. Pregnancy outcome following loop electrosurgical excision procedure (LEEP) a systematic review and meta-analysis. Archives of Gynecology and Obstetrics 2014;289(1):8599.CrossRefGoogle ScholarPubMed
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Genetic/familial high-risk assessment: breast and ovarian. Version 2.2017. 2016. www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf. (Accessed April 27, 2017).
Moyer VA, Force USPST. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:271281.
Couch, FJ, Nathanson, KL, Offit, K. Two decades after BRCA: setting paradigms in personalized cancer care and prevention. Science 2014;343:1466.CrossRefGoogle Scholar
American College of Obstetricians and Gynecologists, ACOG Committee on Practice Bulletins–Gynecology, ACOG Committee on Genetics, Society of Gynecologic Oncologists. ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome. Obstet Gynecol 2009;113: 957–66 (reaffirmed 2015).
Lancaster, JM, Powell, CB, Chen, LM, Richardson, DL, SGO Clinical Practice Committee. Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol 2015;136:37.CrossRefGoogle ScholarPubMed
King, MC, Wieand, S, Hale, K et al. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA 2001;286:22512256.CrossRefGoogle ScholarPubMed
Moorman, PG, Havrilesky, LJ, Gierisch, JM et al. Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis. J Clin Oncol 2013;31:41884198.CrossRefGoogle ScholarPubMed
Society of Gynecologic Oncology. SGO clinical practice statement: salpingectomy for ovarian cancer prevention. 2013. www.sgo.org/clinical-practice/guidelines/sgo-clinical-practice-statement-salpingectomy-for-ovarian-cancer-prevention/. (Accessed February 18, 2015).
Domchek, SM, Friebel, TM, Singer, CF et al. Association of risk-reducingsurgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 2010;304:967975.CrossRefGoogle ScholarPubMed
Rebbeck, TR, Friebel, T, Wagner, T et al. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 2005;23:78047810.CrossRefGoogle ScholarPubMed
Massad, LS et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2013;17:S1.CrossRefGoogle ScholarPubMed
ACOG Practice Bulletin Number 140, Management of abnormal cervical cancer screening test results and cervical cancer precursors, December 2013.
ACOG Practice Bulletin Number 168, Cervical cancer screening and prevention, October 2016.
Waxman, AG, Chelmow, D, Darragh, TM, Lawson, H, Moscicki, A-B. Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix. Obstet Gynecol 2012;120(6):14651471.CrossRefGoogle ScholarPubMed
National Cancer Institute: Breast Cancer Risk Assessment Tool. [Online] accessed 7/16/2017 2008. www.cancer.goy/bcrisktool/.
National Comprehensive Cancer Network. NCCN Guidelines Version 1.2017 Breast Cancer Risk Reduction. [Online] July 16, 2017. www.nccn.org/professionals/physicians_gls/pdf/breast_risk.pdf.
American College of Obstetricians and Gynecologists. Breast cancer risk assessment and screening in average-risk women. Practice bulletin No. 179. Obstet Gynecol 2017;130: e1e16.CrossRef
Bevers, T. Clinical management of the patient at increased or high risk. [book auth.] Copeland, E, Bland, K. Breast: Comprehensive Management of Benign and Malignant Disease. 4th Edition. s.l.: Saunders Elsevier, 2009, pp. 13811392.Google Scholar
Heisey, R, Carrol, J. Identification and management of women with a family history of breast cancer: practical guide for clinicians. Can Fam Physician October 2016;10:799803.Google Scholar
National Comprehensive Cancer Network. NCCN Guidelines Version 1.2017 Breast Cancer Screening and Diagnosis. [Online] July 17, 2017. www.nccn.org/professionals/physician_gls/pdf/breast-screening.pdf.
Kushi, LH, Doyle, C, McCullough, M et al. and The American Cancer Society 2010 Nutrition and Physical Activity Guidelines Advisory Committee, American Cancer Society guidelines on nutrition and physical activity for cancer prevention. CA: Cancer J Clin. 2012;62:3067. doi:10.3322/caac.20140Google ScholarPubMed
Rosenberg, L, Weber, R, Sjoberg, D, Vickers, A. Impact of self-reported data on the acquistion of multi-generational family history and lifestyle factors among women seen in high-risk breast screening program: a focus on modifiable risk factors and genetic referral. Breast Cancer Res Treat 2017;162:275282.CrossRefGoogle Scholar
Massad, LS, Einstein, MH, Huh, WK et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2013;17(5 Suppl 1): S1S27.CrossRefGoogle Scholar
American College of Obstetricians and Gynecologists. Human papillomavirus vaccination. Committee Opinion No. 704. Obstet Gynecol 2017; 129: e173e178.CrossRef
Markowitz, LE, Hariri, S, Lin, C et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National health and nutrition examination surveys, 2003–2010. J Infect Dis 2013;208(3):385393.CrossRefGoogle ScholarPubMed
Khan, MJ, Castle, PE, Lorincz, AT et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005;97(14):10721079.CrossRefGoogle ScholarPubMed
Munoz, N, Bosch, FX, de Sanjose, S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348(6):518527.CrossRefGoogle ScholarPubMed
Viens, LJ, Henley, SJ, Watson, M et al. Human papillomavirus-associated cancers – United States, 2008–2012. MMWR Morb Mortal Wkly Rep 2016;65(26):661666.CrossRefGoogle ScholarPubMed
Meites, E, Kempe, A, Markowitz, LE. Use of a 2-dose schedule for human papillomavirus vaccination – updated recommendations of the advisory committee on immunization practices.MMWR Morb Mortal Wkly Rep 2016;65(49):14051408.CrossRefGoogle ScholarPubMed
Olsson, SE, Kjaer, SK, Sigurdsson, K et al. Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection. Hum Vaccin 2009;5(10):696704.CrossRefGoogle ScholarPubMed
Markowitz, LE, Dunne, EF, Saraiya, M et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2014;63(RR–05):130.Google Scholar
Vichnin, M, Bonanni, P, Klein, NP et al. An overview of quadrivalent human papillomavirus vaccine safety: 2006 to 2015. Pediatr Infect Dis J 2015;34(9):983991.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×